Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ani Pharmaceuticals (ANIP) over the last 16 years, with Q3 2025 value amounting to 0.6.

  • Ani Pharmaceuticals' Asset Utilization Ratio rose 1948.21% to 0.6 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.6, marking a year-over-year increase of 1948.21%. This contributed to the annual value of 0.56 for FY2024, which is 399.7% down from last year.
  • Ani Pharmaceuticals' Asset Utilization Ratio amounted to 0.6 in Q3 2025, which was up 1948.21% from 0.57 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Asset Utilization Ratio registered a high of 0.6 during Q3 2025, and its lowest value of 0.28 during Q4 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.46, with a median of 0.48 in 2024.
  • In the last 5 years, Ani Pharmaceuticals' Asset Utilization Ratio tumbled by 3834.73% in 2021 and then skyrocketed by 5772.73% in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.28 in 2021, then skyrocketed by 51.68% to 0.42 in 2022, then grew by 28.56% to 0.54 in 2023, then dropped by 11.92% to 0.48 in 2024, then grew by 25.78% to 0.6 in 2025.
  • Its Asset Utilization Ratio was 0.6 in Q3 2025, compared to 0.57 in Q2 2025 and 0.52 in Q1 2025.